• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Four-factor prothrombin complex concentrate in trauma patients.

作者信息

Bouzat Pierre, Hunt Beverley J, Juffermans Nicole P

机构信息

CHU Grenoble Alpes, Grenoble Institute Neurosciences, Université Grenoble Alpes, Inserm, U1216, 38000, Grenoble, France.

Pôle d'Anesthésie-Réanimation, Hôpital Albert Michallon, BP 217, 38043, Grenoble, France.

出版信息

Intensive Care Med. 2023 Oct;49(10):1242-1244. doi: 10.1007/s00134-023-07170-0. Epub 2023 Jul 24.

DOI:10.1007/s00134-023-07170-0
PMID:37486378
Abstract
摘要

相似文献

1
Four-factor prothrombin complex concentrate in trauma patients.创伤患者使用四因子凝血酶原复合物浓缩剂
Intensive Care Med. 2023 Oct;49(10):1242-1244. doi: 10.1007/s00134-023-07170-0. Epub 2023 Jul 24.
2
A European consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients.欧洲共识声明：四因子凝血酶原复合物浓缩物在心脏和非心脏手术患者中的应用。
Anaesthesia. 2021 Mar;76(3):381-392. doi: 10.1111/anae.15181. Epub 2020 Jul 17.
3
Reversing Rivaroxaban Anticoagulation as Part of a Multimodal Hemostatic Intervention in a Polytrauma Animal Model.逆转利伐沙班抗凝作用作为多模式止血干预的一部分在多发伤动物模型中的应用。
Anesthesiology. 2021 Oct 1;135(4):673-685. doi: 10.1097/ALN.0000000000003899.
4
Experience with prothrombin complex for the emergent reversal of anticoagulation in rural geriatric trauma patients.在农村老年创伤患者中，使用凝血酶原复合物紧急逆转抗凝的经验。
Surgery. 2012 Oct;152(4):722-6; discussion 726-8. doi: 10.1016/j.surg.2012.07.024. Epub 2012 Sep 1.
5
Prothrombin complex concentrate vs. fresh frozen plasma in adult patients undergoing heart surgery - a pilot randomised controlled trial (PROPHESY trial).成人心脏手术患者使用凝血酶原复合物浓缩剂与新鲜冰冻血浆的比较——一项前瞻性随机对照试验（PROPHESY试验）
Anaesthesia. 2021 Jul;76(7):892-901. doi: 10.1111/anae.15327. Epub 2020 Dec 7.
6
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.使用血栓弹力描记术（ROTEM）指导纤维蛋白原浓缩物和凝血酶原复合物浓缩物给药对严重创伤患者进行目标导向性凝血管理。
Crit Care. 2010;14(2):R55. doi: 10.1186/cc8948. Epub 2010 Apr 7.
7
Use and effectiveness of prothrombin complex concentrate in an emergency department: a review of 15 cases.凝血酶原复合物浓缩剂在急诊科的使用及有效性：15例病例回顾
Acute Med Surg. 2015 Aug 12;3(2):94-100. doi: 10.1002/ams2.141. eCollection 2016 Apr.
8
Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal.活化的凝血酶原复合物与 4 因子凝血酶原复合物在维生素 K 拮抗剂逆转中的应用比较。
Crit Care Med. 2018 Jun;46(6):943-948. doi: 10.1097/CCM.0000000000003090.
9
In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.VIII因子抑制剂患者血浆中活化凝血酶原复合物浓缩物、凝血酶原复合物浓缩物和VIIa因子的VIII因子旁路活性的体外评估：在胶原激活血小板存在下的凝血酶生成试验
J Lab Clin Med. 1993 Mar;121(3):444-52.
10
Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study.四因子凝血酶原复合物浓缩物减少重大创伤患者的同种异体血液产品输血：一项随机多中心双盲优效性研究的研究方案。
Trials. 2021 Sep 16;22(1):634. doi: 10.1186/s13063-021-05524-x.

引用本文的文献

1
Contemporary management of major haemorrhage in critical care.重症监护中大出血的当代处理方法。
Intensive Care Med. 2024 Mar;50(3):319-331. doi: 10.1007/s00134-023-07303-5. Epub 2024 Jan 8.

本文引用的文献

1
Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial.早期给予 4 因子凝血酶原复合物浓缩物治疗创伤大出血风险患者的疗效和安全性：PROCOAG 随机临床试验。
JAMA. 2023 Apr 25;329(16):1367-1375. doi: 10.1001/jama.2023.4080.
2
The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition.《欧洲创伤后大出血及凝血功能障碍管理指南》第六版
Crit Care. 2023 Mar 1;27(1):80. doi: 10.1186/s13054-023-04327-7.
3
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis.
3 因子与 4 因子凝血酶原复合物浓缩物在逆转维生素 K 拮抗剂相关凝血功能障碍中的应用：系统评价和荟萃分析。
Thromb Haemost. 2023 Jan;123(1):40-53. doi: 10.1055/s-0042-1758653. Epub 2023 Jan 10.
4
Coagulopathy Underlying Rotational Thromboelastometry Derangements in Trauma Patients: A Prospective Observational Multicenter Study.创伤患者旋转血栓弹力图异常背后的凝血障碍：一项前瞻性观察性多中心研究
Anesthesiology. 2022 Aug 1;137(2):232-242. doi: 10.1097/ALN.0000000000004268.
5
Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis.四因子凝血酶原复合物浓缩物与创伤相关出血患者的生存改善相关：一项全国范围的倾向评分匹配分析。
J Trauma Acute Care Surg. 2019 Aug;87(2):274-281. doi: 10.1097/TA.0000000000002262.
6
Data-driven Development of ROTEM and TEG Algorithms for the Management of Trauma Hemorrhage: A Prospective Observational Multicenter Study.基于数据的 ROTEM 和 TEG 算法在创伤性出血管理中的开发：一项前瞻性观察性多中心研究。
Ann Surg. 2019 Dec;270(6):1178-1185. doi: 10.1097/SLA.0000000000002825.
7
The role of four-factor prothrombin complex concentrate in coagulopathy of trauma: A propensity matched analysis.四因子凝血酶原复合物浓缩物在创伤性凝血病中的作用：倾向评分匹配分析。
J Trauma Acute Care Surg. 2018 Jul;85(1):18-24. doi: 10.1097/TA.0000000000001938.
8
Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial.使用一线凝血因子浓缩物或新鲜冰冻血浆逆转创伤性凝血病（RETIC）：一项单中心、平行组、开放标签的随机试验。
Lancet Haematol. 2017 Jun;4(6):e258-e271. doi: 10.1016/S2352-3026(17)30077-7. Epub 2017 Apr 28.
9
Assessing the Efficacy of Prothrombin Complex Concentrate in Multiply Injured Patients With High-Energy Pelvic and Extremity Fractures.评估凝血酶原复合物浓缩剂对多发性高能骨盆及四肢骨折患者的疗效。
J Orthop Trauma. 2016 Dec;30(12):653-658. doi: 10.1097/BOT.0000000000000665.
10
Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy.新鲜冷冻血浆输注未能影响凝血功能障碍危重症患者的止血平衡。
J Thromb Haemost. 2015 Jun;13(6):989-97. doi: 10.1111/jth.12908. Epub 2015 Apr 18.